Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « KwdFr.i » - entrée « Hydroxychloroquine (MeSH) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hydroxy-8 quinoléine (composition chimique) < Hydroxychloroquine (MeSH) < Hydroxychloroquine (administration et posologie)  Facettes :

List of bibliographic references indexed by Hydroxychloroquine (MeSH)

Number of relevant bibliographic references: 142.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000072 (2021) Konstantinos Parperis [Chypre (pays), États-Unis]To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.
000073 (2021) Alexis Lacout [France] ; Valere Lounnas [Allemagne] ; Christian Perronne [France]Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients.
000104 (2021) Farah Daou [Liban] ; Gretta Abou-Sleymane [Liban] ; Danielle A. Badro [Liban] ; Nagham Khanafer [France] ; Mansour Tobaiqy [Arabie saoudite] ; Achraf Al Faraj [Liban]The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19.
000110 (2021) Consolato M. Sergi [Canada] ; Brian Chiu [Canada]Targeting NLRP3 inflammasome in an animal model for Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
000119 (2021) Waleed Alhazzani [Canada] ; Laura Evans [États-Unis] ; Fayez Alshamsi [Émirats arabes unis] ; Morten Hylander M Ller [Danemark] ; Marlies Ostermann [Royaume-Uni] ; Hallie C. Prescott [États-Unis] ; Yaseen M. Arabi ; Mark Loeb [Canada] ; Michelle Ng Gong [États-Unis] ; Eddy Fan [Canada] ; Simon Oczkowski [Canada] ; Mitchell M. Levy [États-Unis] ; Lennie Derde [Pays-Bas] ; Amy Dzierba [États-Unis] ; Bin Du [République populaire de Chine] ; Flavia Machado [Brésil] ; Hannah Wunsch [Canada] ; Mark Crowther [Canada] ; Maurizio Cecconi [Italie] ; Younsuck Koh [Corée du Sud] ; Lisa Burry [Canada] ; Daniel S. Chertow [États-Unis] ; Wojciech Szczeklik [Pologne] ; Emilie Belley-Cote [Canada] ; Massimiliano Greco [Italie] ; Malgorzata Bala [Pologne] ; Ryan Zarychanski [Canada] ; Jozef Kesecioglu [Pays-Bas] ; Allison Mcgeer [Canada] ; Leonard Mermel [États-Unis] ; Manoj J. Mammen [États-Unis] ; Sheila Nainan Myatra [Inde] ; Amy Arrington [États-Unis] ; Ruth Kleinpell [États-Unis] ; Giuseppe Citerio [Italie] ; Kimberley Lewis [Canada] ; Elizabeth Bridges [États-Unis] ; Ziad A. Memish ; Naomi Hammond [Australie] ; Frederick G. Hayden [États-Unis] ; Muhammed Alshahrani [Arabie saoudite] ; Zainab Al Duhailib [Canada, Arabie saoudite] ; Greg S. Martin [États-Unis] ; Lewis J. Kaplan [États-Unis] ; Craig M. Coopersmith [États-Unis] ; Massimo Antonelli [Italie] ; Andrew Rhodes [Royaume-Uni]Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update.
000139 (2021) William R. Wolowich [États-Unis] ; Young M. Kwon [États-Unis]Simulation of Drug in the Lung Can Be Misleading.
000164 (2021) Mohit Goyal [Oman]SLE patients are not immune to covid-19: importance of sending the right message across.
000167 (2021) Masoomeh Sofian [Iran] ; Ali Akbar Velayati [Iran] ; Mohammad Banifazl [Iran] ; Fatemeh Fotouhi [Iran] ; Mona Sadat Larijani [Iran] ; Neda Afzali [Iran] ; Amitis Ramezani [Iran]SARS-CoV‑2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms.
000192 (2021) Alexis Mathian [France] ; Zahir Amoura [France]Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al.
000195 (2021) Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.
000197 (2021) Paolo Agostinis [Italie] ; Valentina Vianello [Italie] ; Elena Dereani [Italie] ; Giuseppe Caruso [Italie] ; Beatrice Montessoro [Italie] ; Marco Taurian [Italie] ; Antonio Di Chiara [Italie] ; Vincenzo Patruno [Italie] ; Francesco Cavallin [Italie] ; Gian Paolo Fadini [Italie] ; Anna Aldovini [États-Unis] ; Anna Baritussio [Italie] ; Francesco Curcio [Italie] ; Carlo Tascini [Italie] ; Aldo Baritussio [Italie]Response to a massive SARS-CoV-2 infection in a nursing home transformed into a caring center.
000198 (2021) Francesca Romana Spinelli [Italie] ; Fulvia Ceccarelli [Italie] ; Manuela Di Franco [Italie] ; Fabrizio Conti [Italie]Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis.
000208 (2021) Amandeep Goyal [États-Unis] ; Pankaj Bansal [États-Unis]Reply to letter to editor by McCullough.
000209 (2021) Miao Zhang [République populaire de Chine] ; Xueting Yao [République populaire de Chine] ; Cheng Cui [République populaire de Chine] ; Xu Liu [République populaire de Chine] ; Haiyan Li [République populaire de Chine] ; Dongyang Liu [République populaire de Chine]Reply to Wolowich and Kwon.
000210 (2021) David Hajage [France] ; Valérie Pourcher [France] ; Olivier Paccoud [France] ; Alexandre Bleibtreu [France] ; Eric Caumes [France] ; Florence Tubach [France]Reply to Million et al.
000211 (2021) Sebastian E. Sattui [États-Unis] ; Elizabeth R. Graef [États-Unis] ; Jean W. Liew [États-Unis] ; Jeffrey A. Sparks [États-Unis] ; Alfred H J. Kim [États-Unis]Reply to 'Taking a stand against the politicization of medical research: how "swinging the pendulum" poses a hazard to clinical trials, study participants, and the progress of science'.
000217 (2021) Peter A. Mccullough [États-Unis]Regarding: "Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019".
000226 (2021) Minh Patrick Lê [France] ; Nathan Peiffer-Smadja [France] ; Jeremie Guedj [France] ; Nadège Neant [France] ; France Mentré [France] ; Florence Ader [France] ; Yazdan Yazdanpanah [France] ; Gilles Peytavin [France]Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response.
000237 (2021) Matteo Bianco [Italie] ; Carlo Alberto Biolè [Italie] ; Enrico Cerrato [Italie]QT Interval in Patients With COVID-19.
000238 (2021) Ingrid Berling [Australie] ; Robert S. Hoffman [États-Unis] ; Sophie Gosselin [Canada]QT Interval in Patients With COVID-19.
000239 (2021) Christina F. Yen [États-Unis] ; David J. Shim [États-Unis] ; Howard S. Gold [États-Unis]QT Interval in Patients With COVID-19-Reply.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Hydroxychloroquine (MeSH)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Hydroxychloroquine (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Hydroxychloroquine (MeSH)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021